Simulating the phase II metabolism of raloxifene on a screen-printed electrode
Simulating the phase II metabolism of raloxifene on a screen-printed electrode
About this item
Full title
Author / Creator
Publisher
Ottawa: NRC Research Press
Journal title
Language
English
Formats
Publication information
Publisher
Ottawa: NRC Research Press
Subjects
More information
Scope and Contents
Contents
Raloxifene (RLX) is a selective estrogen receptor modulator widely used for the treatment of osteoporosis in post-menopause women. Toxicological in vitro studies suggested the reactivity of RLX through phase I metabolism. Herein, we describe a simple and inexpensive method for monitoring the reactive metabolism and detoxification of RLX by electroc...
Alternative Titles
Full title
Simulating the phase II metabolism of raloxifene on a screen-printed electrode
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotraccpiq_509015992
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotraccpiq_509015992
Other Identifiers
ISSN
0008-4042
E-ISSN
1480-3291
DOI
10.1139/cjc-2017-0279
